SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · IEX Real-Time Price · USD
16.16
+0.19 (1.19%)
At close: Jul 26, 2024, 4:00 PM
16.37
+0.21 (1.30%)
After-hours: Jul 26, 2024, 4:56 PM EDT
SI-BONE Market Cap
SI-BONE has a market cap or net worth of $665.87 million as of July 26, 2024. Its market cap has decreased by -30.83% in one year.
Market Cap
665.87M
Enterprise Value
546.78M
1-Year Change
-30.83%
Ranking
Category
Stock Price
$16.16
Market Cap Chart
Since October 17, 2018, SI-BONE's market cap has increased from $437.20M to $665.87M, an increase of 52.30%. That is a compound annual growth rate of 7.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 658.00M | -22.60% |
| Dec 29, 2023 | 850.10M | 81.18% |
| Dec 30, 2022 | 469.20M | -36.92% |
| Dec 31, 2021 | 743.80M | -23.13% |
| Dec 31, 2020 | 967.60M | 79.99% |
| Dec 31, 2019 | 537.60M | 5.74% |
| Dec 31, 2018 | 508.40M | 16.29% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cassava Sciences | 662.07M |
| IGM Biosciences | 660.92M |
| UroGen Pharma | 658.31M |
| Astria Therapeutics | 657.31M |
| Arcturus Therapeutics Holdings | 650.94M |
| Avid Bioservices | 647.26M |
| Annexon | 647.24M |
| PetIQ | 646.20M |